Hydrocodone Bitartrate And Acetaminophen
Product Images NDC 63874-293

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Hydrocodone Bitartrate And Acetaminophen (NDC 63874-293). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Altura Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

This Is An Image Of The Label For 5 mg/500 mg Hydrocodone Bitartrate And Acetaminophen Tablets. (63874 0203 30 1)

This Is An Image Of The Label For 5 mg/500 mg Hydrocodone Bitartrate And Acetaminophen Tablets. (63874 0203 30 1)
This is a medication package for Hydrocodone Bitartrate and Acetaminophen, a generic medication for Vicodin. The package contains 30 tablets of 5mg Hydrocodone and 500mg Acetaminophen. The package has a warning to keep out of children's reach and instructions to refer to the full disclosure book regarding indications, dosage, and precautions. The medication package was packaged by Altura Pharmaceuticals, Inc. in Santa Fe Springs, CA.*
FDA Label Image

This Is An Image Of The Label For 7.5 mg/750 mg Hydrocodone Bitartrate And Acetaminophen Tablets. (63874 0230 30 1)

FDA Label Image

This Is An Image Of The Label For 10 mg/660 mg Hydrocodone Bitartrate And Acetaminophen Tablets. (63874 0279 30 1)

FDA Label Image

This Is An Image Of The Label For 10 mg/500 mg Hydrocodone Bitartrate And Acetaminophen Tablets. (63874 0293 30 1)

This Is An Image Of The Label For 10 mg/500 mg Hydrocodone Bitartrate And Acetaminophen Tablets. (63874 0293 30 1)
This is a pharmaceutical drug label for a generic version of medication called Lortab, which contains the active ingredients acetaminophen and hydrocodone bitartrate. The label displays dosage information, quantity, and warnings for usage. It is manufactured by Altura Pharmaceuticals in Santa Fe Springs, California.*
FDA Label Image

This Is An Image Of The Label For 7.5 mg/500 mg Hydrocodone Bitartrate And Acetaminophen Tablets. (63874 0295 30 1)

This Is An Image Of The Label For 7.5 mg/500 mg Hydrocodone Bitartrate And Acetaminophen Tablets. (63874 0295 30 1)
This is a label for a medication. It contains information about the drug, such as its ingredients (acetaminophen and hydrocodone) and dosage instructions. The label also includes a warning to keep the medication out of children's reach and a reference to a full disclosure book for more information about dosage and precautions. Finally, there is information about the company that packaged the medication.*
FDA Label Image

This Is An Image Of The Label For 10 mg/325 mg Hydrocodone Bitartrate And Acetaminophen Tablets. (63874 0834 30 1)

This Is An Image Of The Label For 10 mg/325 mg Hydrocodone Bitartrate And Acetaminophen Tablets. (63874 0834 30 1)
This is a label for a prescription medication called Hydrocodone Bit/APAP Tablet. It contains 10mg of Hydrocodone bitartrate and 325mg of Acetaminophen. It is a generic version of the medication Norco. The label warns to keep it away from children and provides contact information for its packaging company, Altura Pharmaceuticals. The rest of the text appears to be jumbled and not-readable.*
FDA Label Image

This Is An Image Of The Label For 10 mg/650 mg Hydrocodone Bitartrate And Acetaminophen Tablets. (63874 0861 30 1)

FDA Label Image

This Is An Image Of The Structural Formula Of Hydrocodone Bitartrate. (Hydrobitapap 1)

FDA Label Image

This Is An Image Of The Structural Formula Of Acetaminophen. (Hydrobitapap 2)

This Is An Image Of The Structural Formula Of Acetaminophen. (Hydrobitapap 2)
This is a chemical formula for a compound called CHaNO with a molecular weight of 151.18.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.